Skip to main content
Journal of Ophthalmic Inflammation and Infection
Fig. 7 | Journal of Ophthalmic Inflammation and Infection

Fig. 7

From: Preventing relapse in non-infectious uveitis affecting the posterior segment of the eye – evaluating the 0.2 μg/day fluocinolone acetonide intravitreal implant (ILUVIEN®)

Fig. 7

Angiograms from a patient with birdshot retinochoroiditis before a and after being treated with the 0.2 μg/day FAc intravitreal implant b before then also being treated later with adalimumab c. Figure 7 a shows images of the left eye in colour fundus (left panel) and fundus fluorescein angiography (right) in March 2016. Figure 7 b shows images taken in June 2016 after treatment with the FAc implant and shows no change in the choroidal lesions. Figure 7c shows complete resolution of choroidal dark spots in May 2019. At this point adalimumab had also been given (administered in January 2019)

Back to article page